Most common genotypes and risk factors for HCV in Gaza strip: A cross sectional study

Virology Journal

Volumn 6, Issue , 2009, Pages

  Ayesh, Basim M ^a,b   Zourob, Sofia S ^a   Abu Jadallah, Salah Y ^b   Shemer Avni, Yonat ^c  

^a Palestinian Authority   (Palestine)

^b ISLAMIC UNIVERSITY OF GAZA   (Palestine)

^c BEN GURION UNIVERSITY OF THE NEGEV   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; BLOOD TRANSFUSION; CONTROLLED STUDY; FEMALE; GENETIC VARIABILITY; HEPATITIS C; HUMAN; MAJOR CLINICAL STUDY; MALE; MIXED INFECTION; MORBIDITY; RISK FACTOR; STRUCTURED QUESTIONNAIRE; SURGICAL TECHNIQUE; TRAVEL; VIRUS TRANSMISSION; CLASSIFICATION; CLUSTER ANALYSIS; CROSS INFECTION; CROSS-SECTIONAL STUDY; DISEASE TRANSMISSION; DNA SEQUENCE; GENETICS; GENOTYPE; HEPATITIS C VIRUS; ISOLATION AND PURIFICATION; MIDDLE AGED; MIDDLE EAST; PHYLOGENY; SEQUENCE HOMOLOGY; VIROLOGY;

HEPATITIS C VIRUS;

ADULT; CLUSTER ANALYSIS; CROSS INFECTION; CROSS-SECTIONAL STUDIES; FEMALE; GENOTYPE; HEPACIVIRUS; HEPATITIS C; HUMANS; MALE; MIDDLE AGED; MIDDLE EAST; PHYLOGENY; RISK FACTORS; SEQUENCE ANALYSIS, DNA; SEQUENCE HOMOLOGY;

EID: 68749084955     PISSN: None     EISSN: 1743422X     Source Type: Journal    
DOI: 10.1186/1743-422X-6-105     Document Type: Article

References (36)

1. Prevention and control of infections with hepatitis viruses in correctional settings. Centers for Disease Control and Prevention. C Weinbaum R Lyerla HS Margolis, MMWR Recomm Rep. 2003 52 RR-1 1 36 12562146
2. Human oncogenic viruses: hepatitis B and hepatitis C viruses and their role in hepatocarcinogenesis. VE Gurtsevitch, Biochemistry (Mosc) 2008 73 5 504 513 10.1134/S0006297908050039 18605975 (Pubitemid 351775074)
3. Epidemiology of HCV infection. V Baldo T Baldovin R Trivello A Floreani, Curr Pharm Des 2008 14 17 1646 1654 10.2174/138161208784746770 18673187 (Pubitemid 351998588)
4. Health Status in Palestine. Palestinian health information center, Ministry of Health Annual Report State of Palestine Ministry of Health, Gaza 2005
5. HCV-related morbidity in a rural community of Egypt. MK Mohamed I Bakr M El-Hoseiny N Arafa A Hassan S Ismail M Anwar M Attala C Rekacewicz K Zalata M Abdel-Hamid G Esmat A Fontanet, J Med Virol 2006 78 9 1185 1189 10.1002/jmv.20679 16847958 (Pubitemid 44182234)
6. Hepatitis C. World Health Organization, Geneva: WHO 2002
7. Prevalence of hepatitis C virus antibodies among health care workers in Damascus, Syria. BM Othman FS Monem, Saudi Med J 2001 22 7 603 605 11479642
8. Age-specific prevalence of antibody to hepatitis C virus among the Saudi population. TMF Bakir, Saudi Med J 1992 24 7 321 324
9. Hepatitis C virus infection in hemodialysis patients in Jordan. RA Said YY Hamzeh NS Mehyar MS Rababah, Saudi J Kidney Dis Transpl 1995 6 2 140 143 18583853
10. Very high prevalence of hepatitis B and C in Bukharian Jewish immigrants to Israel. F Glikberg J Brawer-Ostrovsky Z Ackerman, J Clin Gastroenterol 1997 24 1 30 33 10.1097/00004836-199701000-00006 9013347 (Pubitemid 27051944)
11. Structural biology of hepatitis C virus. F Penin J Dubuisson FA Rey D Moradpour JM Pawlotsky, Hepatology 2004 39 1 5 19 10.1002/hep.20032 14752815 (Pubitemid 38461460)
12. The hepatitis C virus: overview. R Purcell, Hepatology 1997 26 3 Suppl 1 11S 14S 10.1002/hep.510260702 9305657
13. Clinical significance of hepatitis C virus genotypes. NN Zein, Clin Microbiol Rev 2000 13 2 223 235 10755999 10.1128/CMR.13.2.223-235.2000 (Pubitemid 30205426)
14. Distribution of hepatitis C virus genotypes in the Middle East. S Ramia J Eid-Fares, Int J Infect Dis 2006 10 4 272 277 10.1016/j.ijid.2005.07.008 16564719 (Pubitemid 43870211)
15. MA Feitelson, Hepatitis C Virus: From Laboratory to Clinic Cambridge University Press, UK 2002
16. Hepatitis C virus infection and liver steatosis. F Ramalho, Antiviral Res 2003 60 2 125 127 10.1016/j.antiviral.2003.08.007 14638408 (Pubitemid 37452456)
17. Chronic hepatitis C: updated Swedish consensus. R Wejstl A Alaeus B Fischler O Reichard I Uhnoo O Weiland Swedish National Expert Panel for the treatment of chronic hepatitis C, Scand J Infect Dis 2003 35 8 445 451 10.1080/00365540310013252 14514142 (Pubitemid 37142430)
18. Hepatitis C virus genotype 5: epidemiological characteristics and sensitivity to combination therapy with interferon-alpha plus ribavirin. F Legrand-Abravanel K Sandres-Sauné K Barange L Alric J Moreau P Desmorat JP Vinel J Izopet, J Infect Dis 2004 189 8 1397 1400 10.1086/382544 15073676 (Pubitemid 38543588)
19. Hepatitis C virus infection and genotypes in Southern Israel and the Gaza Strip. Y Shemer-Avni Z el Astal O Kemper KJ el Najjar A Yaari N Hanuka M Margalith E Sikuler, J Med Virol 1998 56 3 230 233 10.1002/(SICI)1096- 9071(199811)56:3<230::AID-JMV9>3.0.CO;2-8 9783690
20. Clinical course and outcome of a nosocomial outbreak of hepatitis C in a urology ward. LM Pekova P Teocharov A Sakarev, J Hosp Infect 2007 67 1 86 91 10.1016/j.jhin.2007.06.010 17719679 (Pubitemid 47377730)
21. Molecular epidemiology of a hepatitis C virus outbreak in a hemodialysis unit in Italy. E Spada I Abbate E Sicurezza A Mariano V Parla S Rinnone M Cuccia MR Capobianchi A Mele, J Med Virol 2008 80 2 261 267 10.1002/jmv.21088 18098132
22. Hepatitis C genotypes/subtypes among chronic hepatitis patients in Saudi Arabia. OA Shobokshi FE Serebour LI Skakni, Saudi Med J 2003 24 Suppl 2 S87 91 12897908
23. Correlation between virus genotype and chronicity rate in acute hepatitis C. P Amoroso M Rapicetta ME Tosti A Mele E Spada S Buonocore G Lettieri P Pierri P Chionne AR Ciccaglione L Sagliocca, J Hepatol 1998 28 6 939 944 10.1016/S0168-8278(98)80340-1 9672167 (Pubitemid 28275970)
24. Hepatitis C virus genotypes in the United States: epidemiology, pathogenicity, and response to interferon therapy. Collaborative Study Group. NN Zein J Rakela EL Krawitt KR Reddy T Tominaga DH Persing, Ann Intern Med 1996 125 8 634 639 8849147
25. Hepatitis C genotype 4: What we know and what we don't yet know. SM Kamal IA Nasser, Hepatology 2008 47 4 1371 1383 10.1002/hep.22127 18240152 (Pubitemid 351547923)
26. Algorithmic approach to high-throughput molecular screening for alpha interferon-resistant genotypes in hepatitis C patients. S Sreevatsan JB Bookout FM Ringpis MR Pottathil DJ Marshall MD Arruda C Murvine L Fors RM Pottathil RR Barathur, J Clin Microbiol 1998 36 7 1895 1901 9650932
27. Acute hepatitis C virus infection after a travel in India. S Jauréguiberry L Grandière-Pérez S Ansart H Laklache S Métivier E Caumes, J Travel Med 2005 12 1 55 56 15996468
28. Management of hepatitis C virus genotype 4. AA Abdo SS Lee, J Gastroenterol Hepatol 2004 19 11 1233 1239 10.1111/j.1440-1746.2003.03325.x 15482528 (Pubitemid 39481755)
29. Evidence of patient-to-patient transmission of hepatitis C virus through contaminated intravenous anaesthetic ampoules. GF Tallis GM Ryan SB Lambert DS Bowden R McCaw CJ Birch M Moloney JA Carnie SA Locarnini GJ Rouch MG Catton, J Viral Hepat 2003 10 3 234 239 10.1046/j.1365-2893.2003.00424.x 12753344 (Pubitemid 36629674)
30. Iatrogenic transmission of hepatitis C virus (HCV) by an anesthesiologist: comparative molecular analysis of the HCV-E1 and HCV-E2 hypervariable regions. Y Shemer-Avni M Cohen A Keren-Naus E Sikuler N Hanuka A Yaari E Hayam L Bachmatov R Zemel R Tur-Kaspa, Clin Infect Dis 2007 45 4 e32 38 10.1086/520014 17638183
31. The contribution of transfusion to HCV infection in England. K Soldan M Ramsay A Robinson H Harris N Anderson E Caffrey C Chapman A Dike G Gabra A Gorman A Herborn P Hewitt N Hewson DA Jones C Llewelyn E Love V Muddu V Martlew A Townley, Epidemiol Infect 2002 129 3 587 591 10.1017/S0950268802007744 12558342
32. Evidence of hepatitis in patients receiving transfusions of blood components containing antibody to hepatitis C. SK Aoki PV Holland LP Fernando IK Kuramoto S Anderson K Sazama V Schoening P Johnson JC Wilber L Fenner HJ Alter, Blood 1993 82 3 1000 1005 7687886
33. A High Risk of Hepatitis C Infection among Egyptian Blood Donors: The Role of Parenteral Drug Abuse. S Bassily KC Hyams RA Fouad MD Samaan RG Hibbs, Am J Trop Med Hyg 1995 52 6 503 505 7541968
34. World medical association declaration of Helsinki: Ethical Principles for Medical Research Involving Human Subjects. World Medical Association, 2007 http://www.wma.net/e/policy/b3.htm
35. Typing of hepatitis C virus isolates and characterization of new subtypes using a line probe assay. L Stuyver R Rossau A Wyseur M Duhamel B Vanderborght H Van Heuverswyn G Maertens, J Gen Virol 1993 74 Pt 6 1093 1102 10.1099/0022-1317-74-6-1093 8389799
36. CLUSTAL W: improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalties and weight matrix choice. JD Thompson DG Higgins TJ Gibson, Nucleic Acids Res 1994 22 22 4673 4680 7984417 10.1093/nar/22.22.4673